These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37623837)

  • 21. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
    Zhou Y; Ren J; Li P; Ma R; Zhou M; Zhang N; Kong X; Hu Z; Xiao X
    Arch Med Res; 2019 Jul; 50(5):249-256. PubMed ID: 31593848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
    Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
    Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD.
    Al-Obaide MAI; Singh R; Datta P; Rewers-Felkins KA; Salguero MV; Al-Obaidi I; Kottapalli KR; Vasylyeva TL
    J Clin Med; 2017 Sep; 6(9):. PubMed ID: 28925931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
    Barrios C; Beaumont M; Pallister T; Villar J; Goodrich JK; Clark A; Pascual J; Ley RE; Spector TD; Bell JT; Menni C
    PLoS One; 2015; 10(8):e0134311. PubMed ID: 26241311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease.
    Zhu Y; Dai L; Yu X; Chen X; Li Z; Sun Y; Liang Y; Wu B; Wang Q; Wang X
    Mol Biol Rep; 2022 Nov; 49(11):10521-10529. PubMed ID: 36129598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction.
    Du J; Xu J; Wang X; Liu Y; Zhao X; Zhang H
    Int Urol Nephrol; 2020 Dec; 52(12):2321-2327. PubMed ID: 32734505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease.
    Zhang B; Wan Y; Zhou X; Zhang H; Zhao H; Ma L; Dong X; Yan M; Zhao T; Li P
    Front Pharmacol; 2022; 13():872988. PubMed ID: 35548353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
    Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
    Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease.
    Lin Z; Zhang D; Zhang X; Guo W; Wang W; Zhang Y; Liu Z; Bi Y; Wu M; Lin Z; Lu X
    BMC Nephrol; 2023 May; 24(1):154. PubMed ID: 37259071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus.
    Teng Z; Feng J; Liu R; Dong Y; Chen H; Xu J; Jiang X; Li R; Lv P
    Diabetes Metab Syndr Obes; 2022; 15():1985-1994. PubMed ID: 35814027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
    Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
    Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L
    Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.